금연 보조제 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2018-2028년) : 제품별, 최종사용자별, 지역별, 경쟁

Global Smoking Cessation Aids Market has valued at USD 23.02 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 11.40% through 2028. The Global Smoking Cessation Aids Market is a dynamic and rapidly evolving sector within the broader healthcare industry. This market is dedicated to providing solutions and support to individuals looking to quit smoking, a critical endeavour given the well-documented health risks associated with tobacco use. The market encompasses a wide range of products and services aimed at assisting smokers on their journey toward becoming smoke-free. This overview provides insight into the key aspects, trends, and factors that define the Global Smoking Cessation Aids Market.

The Global Smoking Cessation Aids Market has witnessed substantial growth in recent years, fueled by a combination of factors. Rising awareness of the health hazards of smoking, government initiatives to curb tobacco consumption, technological advancements in cessation aids, and changing societal norms have collectively driven demand for smoking cessation products and services. As a result, the market has expanded significantly, with a wide array of options available to help individuals quit smoking.

Key Market Drivers

Rising Awareness and Health Concerns

Health Awareness: Increased awareness of the severe health risks associated with smoking is a significant driver. The public is now more informed about the link between smoking and conditions like lung cancer, heart disease, and respiratory problems. This awareness motivates individuals to quit smoking and seek assistance, boosting the demand for cessation aids.

Personal Well-being: People are increasingly concerned about their own well-being and longevity. Smoking cessation is seen as a crucial step towards a healthier life. Individuals are willing to invest in cessation aids as they prioritize their health and aim for a smoke-free future.

Government Initiatives and Regulations

Deterrent Measures: Governments worldwide have imposed regulations such as higher taxes on tobacco products, graphic warning labels, and restrictions on smoking in public places. These measures make smoking less affordable and socially acceptable, compelling smokers to consider quitting.

Public Health Agenda: Governments prioritize public health, and combating smoking is a key part of this agenda. They actively promote smoking cessation programs, creating a conducive environment for the adoption of cessation aids.

Technological Advancements in Smoking Cessation Aids

Personalized Solutions: Modern smoking cessation aids leverage technology to offer personalized solutions. Mobile apps, for instance, provide tailored plans, progress tracking, and real-time support. This level of customization makes it easier for smokers to quit, increasing the effectiveness of these aids.

Harm Reduction: Products like e-cigarettes and NRT have gained popularity due to their harm reduction approach. Smokers can satisfy their nicotine cravings without the harmful toxins found in traditional cigarettes, making these aids a safer choice for those looking to quit.

Changing Lifestyles and Social Stigma

Social Acceptance: Smoking is no longer socially accepted to the extent it once was. Smokers often face stigmatization from their peers and communities. This social pressure acts as a strong motivator for individuals to quit, leading them to seek cessation aids.

Health-Conscious Living: The global trend towards health-conscious living is driving individuals to make healthier choices. Quitting smoking aligns with this lifestyle shift, and cessation aids support this transition, making it more likely for people to quit successfully.

Rising Awareness and Health Concerns, Government Initiatives and Regulations, Technological Advancements in Smoking Cessation Aids, and Changing Lifestyles and Social Stigma all play critical roles in driving the growth of the Global Smoking Cessation Aids Market. These factors collectively create an environment where quitting smoking is not only desirable but also accessible and supported, leading to an increased demand for smoking cessation aids.

Key Market Challenges

Lack of Access and Affordability

One of the most significant challenges faced by the smoking cessation aids market is the limited access and affordability of these products. In many regions, especially low-income and developing countries, access to smoking cessation aids is restricted. Even when available, these aids can be expensive, making them inaccessible to a significant portion of the smoking population. This lack of affordability and accessibility hinders the market's growth, as many potential users are unable to obtain or afford the necessary aids to quit smoking.

Perceived Effectiveness and Safety Concerns

Another challenge is the perception of the effectiveness and safety of smoking cessation aids. Some potential users may be skeptical about the success rates of these products or concerned about potential side effects. This skepticism can lead individuals to avoid using cessation aids altogether, choosing instead to rely on unproven methods or attempting to quit smoking without assistance. Overcoming these concerns and building trust in the effectiveness and safety of cessation aids is crucial for market growth.

Tobacco Industry Influence and Marketing

The tobacco industry's influence and marketing efforts pose a significant obstacle to the growth of the smoking cessation aids market. Tobacco companies often lobby against stringent regulations and promote alternative products that claim to be less harmful, such as e-cigarettes. This marketing can confuse consumers and deter them from seeking proven smoking cessation aids. The tobacco industry's substantial financial resources and advertising campaigns can overshadow the efforts to promote smoking cessation, making it challenging for the market to compete effectively.

The Global Smoking Cessation Aids Market faces significant challenges related to access and affordability, perceived effectiveness and safety concerns, and the influence of the tobacco industry. Addressing these challenges is essential for the market to continue its growth and help individuals worldwide quit smoking and improve their overall health.

Key Market Trends

Rise in Digital Smoking Cessation Solutions:

In recent years, there has been a significant trend toward digital smoking cessation solutions. Mobile applications, online support communities, and telemedicine services have gained popularity as convenient and accessible tools for individuals looking to quit smoking. These digital solutions offer personalized plans, real-time tracking, and immediate support, making it easier for smokers to access help when and where they need it. This trend aligns with the increasing use of technology in healthcare and provides a promising avenue for the market's growth.

Emergence of Nicotine Replacement Therapies (NRTs):

Nicotine Replacement Therapies (NRTs) continue to evolve and expand within the smoking cessation aids market. NRTs include various products such as nicotine patches, gum, lozenges, and inhalers. The trend is shifting toward innovative NRT delivery methods and formulations that enhance effectiveness and user experience. These products offer smokers a controlled way to manage nicotine withdrawal symptoms while avoiding the harmful toxins in tobacco smoke, making them an attractive choice for those looking to quit.

Focus on Behavioural Support and Counselling:

Another notable trend is the growing recognition of the importance of behavioural support and counselling in smoking cessation programs. Many individuals find it challenging to quit smoking due to the psychological aspects of addiction. Consequently, smoking cessation aids increasingly integrate behavioural therapy and counselling into their offerings. This trend acknowledges that addressing the mental and emotional aspects of smoking addiction is essential for long-term success. As a result, more comprehensive and holistic smoking cessation programs are emerging in the market.

The Global Smoking Cessation Aids Market is witnessing trends such as the rise of digital solutions, the evolution of nicotine replacement therapies, and a greater emphasis on behavioural support and counselling. These trends reflect the market's adaptability and commitment to providing effective and diverse options for individuals seeking to quit smoking and improve their health.

Segmental Insights

Product Insights

Based on the category of Product, the nicotine replacement therapy (NRT) segment emerged as the dominant player in the global market for Smoking Cessation Aids in 2022. NRT offers a wide range of delivery methods, including nicotine patches, gum, lozenges, nasal sprays, inhalers, and oral tablets. This variety caters to individual preferences and needs. Smokers can choose the NRT product that aligns with their comfort level and lifestyle, enhancing the chances of successful smoking cessation.

NRT products provide a controlled and gradual reduction in nicotine intake, which is crucial for minimizing withdrawal symptoms and cravings. Smokers can wean themselves off nicotine gradually, reducing the shock of quitting abruptly. This approach increases the likelihood of sustained abstinence from smoking. NRT is available in both prescription and over the counter (OTC) forms, making it accessible to a broad range of smoke over the counteructs, such as nicotine gum and patches, are readily available in pharmacies and stores without a doctor's prescription. This accessibility encourages more individuals to try NRT as a smoking cessation aid. NRT has a track record of effectiveness in helping smokers quit. Clinical studies and real-world use have demonstrated its ability to reduce cravings and withdrawal symptoms, increasing the likelihood of successful smoking cessation. This established efficacy contributes to its dominance in the market.

NRT products deliver nicotine without the harmful toxins found in tobacco smoke. Smokers can satisfy their nicotine cravings while significantly reducing their exposure to carcinogens and other harmful chemicals. This harm reduction approach is appealing to individuals who want to quit smoking without the health risks associated with continued tobacco use. Many healthcare professionals recommend NRT as a safe and effective smoking cessation aid. Their endorsement instills confidence in smokers seeking assistance to quit. Additionally, healthcare providers can prescribe prescription-strength NRT products, further boosting their credibility. NRT can be used in combination with other smoking cessation aids, such as behavioural therapy or prescription medications. This versatility allows for tailored and comprehensive approaches to quitting smoking, increasing the chances of success. These factors are expected to drive the growth of this segment.

End-User Insights

The Retail pharmacies segment is projected to experience rapid growth during the forecast period. Retail pharmacies are easily accessible to the general public. They are typically located in neighbourhoods, shopping centres, and high-traffic areas, making it convenient for individuals looking to purchase smoking cessation aids. Smokers can visit these pharmacies without the need for appointments or referrals, ensuring easy access to cessation products.

Retail pharmacies offer a diverse range of smoking cessation aids, including nicotine replacement therapy (NRT) products, prescription medications, over the counter (OTC) options, and herbal remedies. This wide product selection allows individuals to choose the cessation aid that best suits their preferences and needs. Pharmacists and pharmacy staff are trained healthcare professionals who can provide expert guidance and recommendations to smokers seeking to quit. They can offer information on the various cessation products available, their effectiveness, and potential side effects. This personalized advice enhances the chances of successful smoking cessation. Some smoking cessation medications, such as varenicline (Chantix) and bupropion (Zyban), require a prescription. Retail pharmacies are equipped to dispense these prescription medications, making them a crucial point of access for individuals who need such treatments. Smokers can consult with healthcare providers and obtain their prescriptions conveniently from the pharmacy. These factors collectively contribute to the growth of this segment.

Regional Insights

North America emerged as the dominant player in the global Smoking Cessation Aids market in 2022, holding the largest market share in terms of value. North America, especially the United States, has had a significant smoking population. This large base of smokers creates a substantial market for smoking cessation aids. The desire to quit smoking and the availability of these aids have contributed to North America's prominence.

North America has seen a considerable increase in health awareness and education regarding the risks associated with smoking. As a result, there is a strong motivation among smokers to quit for health reasons, driving the demand for cessation aids.

The region boasts an advanced healthcare infrastructure, including a vast network of retail pharmacies and healthcare providers. This infrastructure ensures easy access to smoking cessation aids, professional guidance, and prescription medications.

North America is home to some of the world's leading pharmaceutical companies, which have developed and marketed smoking cessation medications. This industry's presence contributes to the availability and promotion of these aids. Stringent regulations and insurance coverage for smoking cessation treatments in North America encourage individuals to seek help in quitting. Many health insurance plans cover smoking cessation aids, making them more affordable and accessible. There has been a notable cultural shift in North America towards healthier lifestyles and greater awareness of the social stigma associated with smoking. This shift encourages individuals to quit and seek assistance through cessation aids.

The Asia-Pacific market is poised to be the fastest-growing market, has the largest smoking population globally, with countries like China and India having a significant number of smokers. As awareness of smoking-related health risks grows, more individuals in the region are seeking ways to quit. Similar to North America, the APAC region is experiencing a rising trend in health consciousness. People are becoming more aware of the health risks of smoking and are actively seeking smoking cessation solutions. Governments in APAC countries are taking proactive measures to combat smoking. They are implementing anti-smoking campaigns, imposing higher taxes on tobacco products, and introducing regulations to discourage smoking. These initiatives drive the demand for cessation aids. The growth of the middle class in many APAC countries has increased disposable incomes. This allows more individuals to afford smoking cessation aids, contributing to market growth.

Urbanization often leads to lifestyle changes, including increased awareness of health issues. As more people move to urban areas in the APAC region, the demand for smoking cessation aids is expected to rise.

Key Market Players

• Pfizer Inc.

• GlaxoSmithKline PLC

• Hoffmann-La Roche AG

• Novartis AG

• Johnson and Johnson

• Bayer AG

• Cipla Ltd

• Takeda Pharmaceuticals Co. Ltd

• British American Tobacco PLC

• Kimree Technology Inc

• Imperial Tobacco Ltd

Report Scope:

In this report, the Global Smoking Cessation Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Smoking Cessation Aids Market, By Product:

• Nicotine Replacement Therapy
• Drugs
• Electronic Cigarettes
• Others

Smoking Cessation Aids Market, By End-User:

• Hospital Pharmacies
• Online Channels
• Retail Pharmacies
• Other

Smoking Cessation Aids Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Smoking Cessation Aids Market.

Available Customizations:

• Global Smoking Cessation Aids market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Smoking Cessation Aids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Nicotine Replacement Therapy, Drugs, electronic Cigarettes, Others)
  • 5.2.2. By End-User (Hospital Pharmacies, Online Channels, Retail Pharmacies, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. North America Smoking Cessation Aids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Smoking Cessation Aids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End-User
  • 6.3.2. Canada Smoking Cessation Aids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End-User
  • 6.3.3. Mexico Smoking Cessation Aids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End-User

7. Europe Smoking Cessation Aids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End-User
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Smoking Cessation Aids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End-User
  • 7.3.2. United Kingdom Smoking Cessation Aids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End-User
  • 7.3.3. Italy Smoking Cessation Aids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End-User
  • 7.3.4. France Smoking Cessation Aids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End-User
  • 7.3.5. Spain Smoking Cessation Aids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End-User

8. Asia-Pacific Smoking Cessation Aids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End-User
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Smoking Cessation Aids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End-User
  • 8.3.2. India Smoking Cessation Aids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End-User
  • 8.3.3. Japan Smoking Cessation Aids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End-User
  • 8.3.4. South Korea Smoking Cessation Aids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End-User
  • 8.3.5. Australia Smoking Cessation Aids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End-User

9. South America Smoking Cessation Aids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End-User
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Smoking Cessation Aids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End-User
  • 9.3.2. Argentina Smoking Cessation Aids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End-User
  • 9.3.3. Colombia Smoking Cessation Aids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End-User

10. Middle East and Africa Smoking Cessation Aids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End-User
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Smoking Cessation Aids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End-User
  • 10.3.2. Saudi Arabia Smoking Cessation Aids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End-User
  • 10.3.3. UAE Smoking Cessation Aids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers & Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Smoking Cessation Aids Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. End-User Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Pfizer Inc.
  • 14.5.2. GlaxoSmithKline PLC
  • 14.5.3. Hoffmann-La Roche AG
  • 14.5.4. Novartis AG
  • 14.5.5. Johnson and Johnson
  • 14.5.6. Bayer AG
  • 14.5.7. Cipla Ltd
  • 14.5.8. Takeda Pharmaceuticals Co. Ltd
  • 14.5.9. British American Tobacco PLC
  • 14.5.10. Kimree Technology Inc
  • 14.5.11. Imperial Tobacco Ltd

15. Strategic Recommendations

16. About Us & Disclaimer